🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 7 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/07/2007 | 33,94 | 34,15 | 33,87 | 34,02 | +0,13% | 0,81% | 2.311.200 |
| 13/07/2007 | 34,00 | 34,20 | 33,75 | 33,98 | -0,07% | 1,32% | 1.773.800 |
| 12/07/2007 | 33,90 | 34,07 | 33,78 | 34,00 | +1,25% | 0,86% | 2.000.600 |
| 11/07/2007 | 33,25 | 33,85 | 33,08 | 33,58 | +1,28% | 2,30% | 2.685.400 |
| 10/07/2007 | 32,79 | 33,29 | 32,74 | 33,16 | +0,97% | 1,69% | 1.622.200 |
| 09/07/2007 | 32,52 | 32,99 | 32,39 | 32,84 | +1,34% | 1,85% | 931.200 |
| 06/07/2007 | 32,49 | 32,54 | 32,28 | 32,40 | +0,25% | 0,82% | 1.717.600 |
| 05/07/2007 | 32,11 | 32,46 | 31,82 | 32,32 | +0,86% | 1,99% | 1.147.400 |
| 03/07/2007 | 31,98 | 32,15 | 31,91 | 32,05 | +0,20% | 0,75% | 231.600 |
| 02/07/2007 | 32,03 | 32,08 | 31,78 | 31,98 | +0,31% | 0,92% | 347.000 |
| 29/06/2007 | 32,00 | 32,12 | 31,76 | 31,88 | +0,02% | 1,14% | 780.800 |
| 28/06/2007 | 31,86 | 32,01 | 31,69 | 31,88 | +0,27% | 1,00% | 626.000 |
| 27/06/2007 | 31,27 | 31,90 | 31,09 | 31,79 | +1,99% | 2,59% | 1.171.000 |
| 26/06/2007 | 31,20 | 31,45 | 30,97 | 31,17 | -0,19% | 1,54% | 1.074.200 |
| 25/06/2007 | 31,26 | 31,75 | 31,16 | 31,23 | -0,35% | 1,89% | 1.001.200 |
| 22/06/2007 | 31,77 | 31,90 | 31,29 | 31,34 | -1,37% | 1,92% | 1.684.000 |
| 21/06/2007 | 31,67 | 32,00 | 31,49 | 31,78 | -0,17% | 1,61% | 902.000 |
| 20/06/2007 | 32,11 | 32,14 | 31,74 | 31,83 | -0,81% | 1,23% | 1.265.000 |
| 19/06/2007 | 32,01 | 32,18 | 31,83 | 32,09 | -0,33% | 1,09% | 1.148.400 |
| 18/06/2007 | 32,50 | 32,52 | 32,03 | 32,20 | -0,71% | 1,51% | 1.041.400 |
| 15/06/2007 | 32,52 | 32,68 | 32,19 | 32,43 | +0,92% | 1,52% | 1.427.200 |
| 14/06/2007 | 32,35 | 32,50 | 31,99 | 32,13 | -0,36% | 1,58% | 1.003.200 |
| 13/06/2007 | 32,25 | 32,49 | 32,13 | 32,25 | +0,05% | 1,10% | 700.000 |
| 12/06/2007 | 32,50 | 32,59 | 32,06 | 32,23 | -0,82% | 1,65% | 1.486.400 |
| 11/06/2007 | 32,87 | 33,11 | 32,46 | 32,50 | -1,01% | 1,98% | 645.000 |
| 08/06/2007 | 32,57 | 32,90 | 32,25 | 32,83 | +0,95% | 1,98% | 769.000 |
| 07/06/2007 | 32,98 | 33,25 | 32,47 | 32,52 | -1,81% | 2,37% | 1.064.200 |
| 06/06/2007 | 32,92 | 33,36 | 32,92 | 33,12 | +0,09% | 1,35% | 809.600 |
| 05/06/2007 | 32,59 | 33,22 | 32,55 | 33,09 | +1,02% | 2,06% | 1.123.000 |
| 04/06/2007 | 32,72 | 32,93 | 32,49 | 32,75 | -0,11% | 1,34% | 885.600 |